警馬鞍山截查私家車 檢14萬元大麻拘一人 To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video 【有線新聞】警方在馬鞍山一架私家車檢獲懷疑大麻，市值約14萬元，拘捕一人。 涉案私家車被圍封調查。現場是鞍誠街近新港城中心，昨晚8時許，...
警馬鞍山截查私家車 檢14萬元大麻拘一人 To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video 【有線新聞】警方在馬鞍山一架私家車檢獲懷疑大麻，市值約14萬元，拘捕一人。 涉案私家車被圍封調查。現場是鞍誠街近新港城中心，昨晚8時許，警員截查一輛可疑私家車，在車上檢獲懷疑大麻，包括約680克懷疑大麻花、八包懷疑含有大麻的糖果等。38歲男子涉嫌販毒被捕。
(RTTNews) - After ending the previous session in negative territory, the major U.S. stock indexes are turning in a mixed performance during trading on Wednesday. While the tech-heavy Nasdaq is showing another notable move to the downside, the Dow has moved back to the upside. The Nasdaq fell to a new low for the session in recent trading and is currently down 306.14 points or 1.3 percent at 22,949...
(RTTNews) - After ending the previous session in negative territory, the major U.S. stock indexes are turning in a mixed performance during trading on Wednesday. While the tech-heavy Nasdaq is showing another notable move to the downside, the Dow has moved back to the upside. The Nasdaq fell to a new low for the session in recent trading and is currently down 306.14 points or 1.3 percent at 22,949.04. The S&P 500 is also down 28.52 points or 0.4 percent at 6,889.29, while the narrower Dow is up 266.32 points or 0.5 percent at 49,507.31. The advance by the Dow comes amid a sharp increase by shares of Amgen (AMGN), as the biotech company is surging by 6.5 percent after reporting better than expected fourth quarter results. Strong gains by 3M (MMM), Nike (NKE) and Disney (DIS) are also contributing to the rebound by the blue chip index. Meanwhile, weakness among technology stocks continues to weigh on the Nasdaq, with semiconductor stocks showing a substantial move to the downside. The Philadelphia Semiconductor Index has plunged by 3.9 percent, pulling back further off the record closing high set last Thursday. Advanced Micro Devices (AMD) has helped lead the sector lower, plummeting by 15.8 percent after reporting better than expected fourth quarter results but providing first quarter guidance that disappointed some analysts. Computer hardware and networking stocks are also seeing considerable weakness, while gold stocks are turning in some of the worst performances outside the tech sector despite an increase by the price of the precious metal. On the other hand, housing stocks are extending the rally seen in the previous session, driving the Philadelphia Housing Sector Index up by 3.0 percent. Pharmaceutical stocks are also seeing significant strength on the day, moving notably higher along with energy, airline and banking stocks. In U.S. economic news, payroll processor ADP released a report showing private sector employment in the U.S. increased by much less than ...
Vertigo3d/E+ via Getty Images A recent Jefferies note highlights growing signs of capitulation across the technology and software universe, with technical indicators flashing levels of oversold conditions rarely seen before. According to the firm, roughly 73% of software stocks now screen as oversold, marking the highest reading on record. Broader technology is not far behind, with about 45% of te...
Vertigo3d/E+ via Getty Images A recent Jefferies note highlights growing signs of capitulation across the technology and software universe, with technical indicators flashing levels of oversold conditions rarely seen before. According to the firm, roughly 73% of software stocks now screen as oversold, marking the highest reading on record. Broader technology is not far behind, with about 45% of tech names in oversold territory—also an unprecedented level. Jefferies points out that relative performance has deteriorated sharply as well. The iShares Expanded Tech-Software Sector ETF ( IGV ) versus the S&P 500 ( SP500 ) is now more oversold than at any prior point in its history, underscoring the depth of the recent drawdown. Even IGV itself has slipped into oversold territory. The pressure has been driven largely by heavy selling from long-only investors. Jefferies notes that, at the peak, selling supply outweighed demand by more than five-to-one—an extreme imbalance that typically coincides with periods of stress. While those skews remain elevated, the firm says the pace of selling has begun to ease modestly. Despite the sharp correction, valuations remain relatively elevated, with software stocks still trading around eight times sales. Jefferies suggests the combination of stretched valuations and extreme technical damage will be key factors shaping near-term sentiment in the sector. Software ETFs: ( IGV ), ( XSW ), ( AOTS ), ( HACK ), and ( SPAM ). More on markets Alphabet earnings are in focus as prediction markets price heavy AI emphasis SpaceX–xAI deal reignites IPO countdown as prediction markets take bets on the date Deutsche Bank stands firm on $6,000 gold target as it says the bullish case remains intact ETF inflows shatter records as $165B floods in during the month of January U.S. corporate profits stay on solid footing, as Goldman projects double-digit growth in 2026
Key Points American Express outperformed the market over the past decade. It is well-insulated from interest rate swings. It faces near-term challenges, but its stock looks reasonably valued. 10 stocks we like better than American Express › American Express' (NYSE: AXP) stock has rallied nearly 550% over the past ten years. If we include reinvested dividends, it delivered a total return of 644% --...
Key Points American Express outperformed the market over the past decade. It is well-insulated from interest rate swings. It faces near-term challenges, but its stock looks reasonably valued. 10 stocks we like better than American Express › American Express' (NYSE: AXP) stock has rallied nearly 550% over the past ten years. If we include reinvested dividends, it delivered a total return of 644% -- easily beating the S&P 500's total return of 330%. Will a fresh investment in this blue chip stock today set you up for life? Why is American Express an evergreen investment? American Express is often considered a credit card company, but it doesn't operate the same business model as Visa (NYSE: V) or Mastercard (NYSE: MA). Unlike those two credit card giants, which only co-issue branded cards with banks and don't handle the actual accounts, American Express issues its own cards and handles the accounts through its own bank. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue » Visa and Mastercard generate most of their revenue by charging merchants "swipe fees" whenever their cards are processed, but American Express generates both swipe-fee revenue and interest income from its issued cards. That key difference makes American Express more resistant to macro headwinds for consumer spending and interest rate swings. Higher interest rates generally impact all three companies by curbing consumer spending and reducing their swipe fees, but American Express can offset that pressure by generating higher net interest income. That diversification also provides it with greater protection against proposed caps on swipe fees from merchants and antitrust regulators. What challenges could American Express face? American Express' evergreen business model made it one of Warren Buffett's favorite stocks, but it still faces some near-term challenges. President Trump recently proposed a temporary 10% cap on cre...
It might be a stretch to view Oklo as a long-term passive-income stock, but the growth opportunity is there. Viewing Oklo (OKLO 14.19%) as a passive-income powerhouse before it has generated a profit is a bit optimistic, but investors who can zoom out may see the opportunity. It's not a suitable pick for investors who want high-yield dividend stocks right now. However, Oklo can mirror the path of ...
It might be a stretch to view Oklo as a long-term passive-income stock, but the growth opportunity is there. Viewing Oklo (OKLO 14.19%) as a passive-income powerhouse before it has generated a profit is a bit optimistic, but investors who can zoom out may see the opportunity. It's not a suitable pick for investors who want high-yield dividend stocks right now. However, Oklo can mirror the path of other superstar growth stocks, such as Meta Platforms (META 2.94%), which started as an unprofitable company, scaled its business, and now pays dividends. Meta Platforms has only a 0.29% yield, but that yield, as a reflection of cost basis, is much higher for the people who bought shares 10 years ago. That's the type of opportunity Oklo could provide if it grows rapidly and becomes profitable in the future. The nuclear energy thesis Oklo produces small modular reactors, which are smaller than traditional nuclear reactors, making them more practical at scale. Investors must believe nuclear energy will go mainstream to accumulate Oklo shares, and there are reasons to think that this is the case. Expand NYSE : OKLO Oklo Today's Change ( -14.19 %) $ -11.07 Current Price $ 66.93 Key Data Points Market Cap $12B Day's Range $ 66.00 - $ 77.26 52wk Range $ 17.42 - $ 193.84 Volume 287K Avg Vol 13M Nuclear energy is a carbon-free energy source that provides 24/7 base-load power. This energy can be used as a power source for artificial intelligence (AI) data centers, which is central to the bullish thesis. The U.S. Department of Energy (DOE) has been investing heavily in nuclear energy, with the department touting 2025 as "one of the biggest years in U.S. nuclear energy history." The DOE has approved Oklo's small modular reactor designs. Oklo's Aurora reactor was also selected for the DOE's pilot program. Oklo is already working with big tech Oklo is still a few years away from commercialization, but it's already winning big deals. Oklo and Meta Platforms recently announced that they w...
WBC champion Caroline Dubois will fight WBO belt-holder Terri Harper in a lightweight unification bout on 5 April at the Olympia in London. The long-awaited all-British bout will headline Jake Paul's Most Valuable Promotions' first event in the UK. Ellie Scotney will be co-main event in an undisputed bout while fellow Britons Chantelle Cameron and Emma Dolan are also in action on the undercard in ...
WBC champion Caroline Dubois will fight WBO belt-holder Terri Harper in a lightweight unification bout on 5 April at the Olympia in London. The long-awaited all-British bout will headline Jake Paul's Most Valuable Promotions' first event in the UK. Ellie Scotney will be co-main event in an undisputed bout while fellow Britons Chantelle Cameron and Emma Dolan are also in action on the undercard in world title fights. The fight night sees Sky Sports re-enter the boxing market as a broadcaster after signing a deal with MVP. The broadcaster has a long history in the sport having worked in the past with Eddie Hearn's Matchroom and Frank Warren's Queensberry, but the deal with MVP is their first since opting against renewing their deal with Ben Shalom's Boxxer last summer. "This event represents a major milestone for MVP as we bring our brand to the UK for the first time and do so with Sky Sports, with a card that reflects the scale, depth and ambition of women's boxing today," Nakisa Bidarian, CEO of MVP, said. Scotney, 27, aims to become undisputed champion at super-bantamweight when she takes on WBA title holder Mayelli Flores Rosquero. The unbeaten Scotney can become the fourth British undisputed champion in the four-belt era if she beats the 33-year-old Mexican. Northampton fighter Cameron has the opportunity to become a two-weight world champion at light-middleweight against the unbeaten Michaela Kotaskova in their WBO title fight. Former undisputed light-welterweight champion Cameron's only loss came to Irishwoman Katie Taylor in 2023 while 34-year-old Czech fighter Kotaskova has 11 wins and two draws on her record. Norwich's Dolan, 27, will aim to collect her maiden world title when she faces the vastly experienced IBF super-flyweight champion Irma Garcia. The Mexican has 35 fights compared to Dolan's eight and is 17 years her senior at the age of 44.
bymuratdeniz/iStock via Getty Images Digital Turbine, Inc. ( APPS ) has some problems. Although, if you look at its stock performance in the last five years, down over 90%, this is a pretty basic observation. So what has happened? Despite a flurry of acquisitions in 2021, including AdColony and Fyber for ~$1 billion combined, Digital Turbine’s growth and margins have been underwhelming. Its financ...
bymuratdeniz/iStock via Getty Images Digital Turbine, Inc. ( APPS ) has some problems. Although, if you look at its stock performance in the last five years, down over 90%, this is a pretty basic observation. So what has happened? Despite a flurry of acquisitions in 2021, including AdColony and Fyber for ~$1 billion combined, Digital Turbine’s growth and margins have been underwhelming. Its financial structure feels wobbly. And a fundamental shift in how the Internet works has left Digital Turbine in a challenging spot. The following article reveals that the turnaround required for Digital Turbine to get ahead of its financial obligations may leave its shareholders unsatisfied. Recent Developments Although I have years of familiarity with Digital Turbine because this is my first time covering the stock, I'm going to briefly describe what the business does. The company is involved in mobile advertising and app monetization. It reports two categories: On Device Solutions, ODS, and App Growth Platform, AGP. In its fiscal Q3 2026 results, the company reported ODS revenue of $99.6 million and AGP revenue of $52.6 million (before intercompany eliminations). Segment FQ3 2025 Revenue FQ3 2026 Revenue YoY Growth ODS $91.4M $99.6M +9% AGP $44.2M $52.6M +19% Total Revenue $135.6M $152.2M +12% Click to enlarge As for full fiscal year 2026, the company, again, raised its revenue guidance to between $553 million and $558 million. Adjusted EBITDA guidance was boosted to between $114 million and $117 million. Last year, the company refinanced its debt with a new 4-year $430 million term loan (11.68% interest rate at quarter-end). At the end of fiscal third quarter, outstanding debt was $355 million (matures August 2029). Digital Turbine utilized an ATM issuance (dilution) to help pay this down, but insists this may not be necessary moving forward. Metric (FQ3 2026) Amount (Millions) Total Debt $355M Quarterly Interest Expense $13.6M Non-GAAP Free Cash Flow $6.4M Interest Coverage R...
Nicolas Jooris-Ancion/iStock via Getty Images Introduction My followers may notice that I wrote this prior article to compare Eli Lilly ( LLY ) against its archrival Novo Nordisk ( NVO ), as well as their Big Pharma industry peers, by conducting extensive comparisons among them across valuation, growth, and profitability metrics. I concluded that investors may consider investing in Novo as it was ...
Nicolas Jooris-Ancion/iStock via Getty Images Introduction My followers may notice that I wrote this prior article to compare Eli Lilly ( LLY ) against its archrival Novo Nordisk ( NVO ), as well as their Big Pharma industry peers, by conducting extensive comparisons among them across valuation, growth, and profitability metrics. I concluded that investors may consider investing in Novo as it was undervalued. The purpose of this article is to focus almost solely on Eli Lilly, to put Lilly’s roughly $950 billion market cap to the test through the lens of the competitive landscape within which the company operates, including the threats from generic drugs. That Lilly is a wonderful company should not be controversial. Its execution over the last several years has been extraordinary. Its metabolic franchise, manufacturing prowess, and R&D capabilities have earned it the reputation as the most admired pharmaceutical company in the world. My hypothesis is that this $950 billion price tag of Lilly as an enterprise reflects an increasingly widespread but difficult-to-sustain belief that Lilly will dominate the global GLP-1 and obesity drug markets for the foreseeable future, its current advantage will persist for many years, and it will do so without serious disruptions from competitors—big and small, patented and generic. What Lilly Has Achieved Is Impressive Let me repeat myself: Lilly is a wonderful company today. Through Mounjaro, Lilly has transformed the diabetes market. Through Zepbound, Lilly has established itself as a central force in obesity pharmacotherapy. The company has demonstrated a superb ability to move quickly from trials to approval, to scale up manufacturing in parallel with demand, and to commercialize at a pace most Big Pharma companies can only admire. From 2022 through 2025, Lilly executed extremely well. The first turning point was Mounjaro (tirzepatide). Lilly launched it for type 2 diabetes in 2022, and demand ramped quickly in 2023. By Q2 2023...
At the last Winter Olympics in Beijing four years ago, Team GB won a total of two medals. Both came in the sport of curling. And as the 2026 event in Milan-Cortina gets going, the 10 Scots in the team will again be among the favourites to return home with ribbons around their necks. So, best get an idea of how curling works... Some people will have a rough grasp. Two teams take turns to slide gran...
At the last Winter Olympics in Beijing four years ago, Team GB won a total of two medals. Both came in the sport of curling. And as the 2026 event in Milan-Cortina gets going, the 10 Scots in the team will again be among the favourites to return home with ribbons around their necks. So, best get an idea of how curling works... Some people will have a rough grasp. Two teams take turns to slide granite stones down a 45m-plus sheet of ice towards a target, with those 20kg stones accompanied on their journey by two players brushing furiously. More on that later. The tactical mastery required has led it to be called "chess on ice", but it might also be considered as "bowls on ice". At Olympic level, the rinks - as players are also known - compete in the men's, women's and mixed competitions. The first two involve teams of four, and the latter teams of two, with slightly modified rules. We'll explain that in a bit, too...
Bitcoin is increasingly behaving like a software stock, with its latest correction unfolding alongside the broader software sell-off. The relationship between bitcoin and software equities has strengthened notably. On a 30-day rolling basis, bitcoin’s correlation with the iShares Expanded Tech Software ETF, (IGV), stands at a high 0.73, according to ByteTree. The IGV is down around 20% year to dat...
Bitcoin is increasingly behaving like a software stock, with its latest correction unfolding alongside the broader software sell-off. The relationship between bitcoin and software equities has strengthened notably. On a 30-day rolling basis, bitcoin’s correlation with the iShares Expanded Tech Software ETF, (IGV), stands at a high 0.73, according to ByteTree. The IGV is down around 20% year to date, while bitcoin has fallen 16%. STORY CONTINUES BELOW Don't miss another story. Subscribe to the Crypto Daybook Americas Newsletter today . See all newsletters Sign me up By signing up, you will receive emails about CoinDesk products and you agree to our terms & conditions and privacy policy . IGV is heavily weighted toward software and services names such as Microsoft (MSFT), Oracle (ORCL), Salesforce (CRM), Intuit (INTU) and Adobe (ADBE). While the technology sector appears relatively resilient at the headline level — the Nasdaq 100 (QQQ), is only around 4% below its record high — software stocks have absorbed most of the selling pressure, and bitcoin is increasingly trading in line with this weaker pocket of the market rather than the broader index. As for why software names are getting hammered, the answer is simple: AI. The rapid progress towards fully functioning artificial general intelligence (AGI) is currently being considered an existential issue for software. “There can be no doubt that bitcoin has been caught up in the technology selloff," said ByteTree. "At its heart, bitcoin is an internet stock. Software stocks have been the most recent casualty, and the price of bitcoin has shown similar performance over the past five years, with high correlation.” ByteTree also notes that the average technology bear market lasts about 14 months. With this current downturn having started in October, this suggests pressure could persist through much of 2026. However, ByteTree notes that a resilient economic backdrop could provide support for bitcoin. "Bitcoin is just open-so...
In trading on Tuesday, shares of MSCI Inc (Symbol: MSCI) crossed below their 200 day moving average of $489.11, changing hands as low as $472.69 per share. MSCI Inc shares are currently trading off about 13.1% on the day. The chart below shows the one year performance of MSCI shares, versus its 200 day moving average: Looking at the chart above, MSCI's low point in its 52 week range is $376.41 per...
In trading on Tuesday, shares of MSCI Inc (Symbol: MSCI) crossed below their 200 day moving average of $489.11, changing hands as low as $472.69 per share. MSCI Inc shares are currently trading off about 13.1% on the day. The chart below shows the one year performance of MSCI shares, versus its 200 day moving average: Looking at the chart above, MSCI's low point in its 52 week range is $376.41 per share, with $572.50 as the 52 week high point — that compares with a last trade of $472.01. The MSCI DMA information above was sourced from TechnicalAnalysisChannel.com Click here to find out which 9 other stocks recently crossed below their 200 day moving average » Also see: The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
In trading on Wednesday, shares of Prudential Financial Inc (Symbol: PRU) crossed below their 200 day moving average of $106.44, changing hands as low as $101.12 per share. Prudential Financial Inc shares are currently trading down about 2.9% on the day. The chart below shows the one year performance of PRU shares, versus its 200 day moving average: Looking at the chart above, PRU's low point in i...
In trading on Wednesday, shares of Prudential Financial Inc (Symbol: PRU) crossed below their 200 day moving average of $106.44, changing hands as low as $101.12 per share. Prudential Financial Inc shares are currently trading down about 2.9% on the day. The chart below shows the one year performance of PRU shares, versus its 200 day moving average: Looking at the chart above, PRU's low point in its 52 week range is $90.38 per share, with $119.76 as the 52 week high point — that compares with a last trade of $104.18. The PRU DMA information above was sourced from TechnicalAnalysisChannel.com Click here to find out which 9 other dividend stocks recently crossed below their 200 day moving average » Also see: The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
In trading on Wednesday, shares of Voya Financial Inc (Symbol: VOYA) crossed below their 200 day moving average of $71.68, changing hands as low as $67.97 per share. Voya Financial Inc shares are currently trading down about 5.8% on the day. The chart below shows the one year performance of VOYA shares, versus its 200 day moving average: Looking at the chart above, VOYA's low point in its 52 week ...
In trading on Wednesday, shares of Voya Financial Inc (Symbol: VOYA) crossed below their 200 day moving average of $71.68, changing hands as low as $67.97 per share. Voya Financial Inc shares are currently trading down about 5.8% on the day. The chart below shows the one year performance of VOYA shares, versus its 200 day moving average: Looking at the chart above, VOYA's low point in its 52 week range is $52.4343 per share, with $79.99 as the 52 week high point — that compares with a last trade of $71.91. Click here to find out which 9 other dividend stocks recently crossed below their 200 day moving average » Also see: The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
In trading on Wednesday, shares of CNH Industrial NV (Symbol: CNH) crossed above their 200 day moving average of $11.41, changing hands as high as $11.80 per share. CNH Industrial NV shares are currently trading up about 4.7% on the day. The chart below shows the one year performance of CNH shares, versus its 200 day moving average: Looking at the chart above, CNH's low point in its 52 week range ...
In trading on Wednesday, shares of CNH Industrial NV (Symbol: CNH) crossed above their 200 day moving average of $11.41, changing hands as high as $11.80 per share. CNH Industrial NV shares are currently trading up about 4.7% on the day. The chart below shows the one year performance of CNH shares, versus its 200 day moving average: Looking at the chart above, CNH's low point in its 52 week range is $9 per share, with $14.27 as the 52 week high point — that compares with a last trade of $11.74. Click here to find out which 9 other stocks recently crossed above their 200 day moving average » Also see: The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Hims & Hers is moving beyond prescriptions to preventative testing. Hims & Hers (HIMS 3.72%) announced today the launch of an early detection cancer test, bringing more value to its lab business. This is another product launch that isn't about pushing pills or slotting into the existing insurance ecosystem; it's fundamentally disruptive to the medical industry. In this video, I explain why this is...
Hims & Hers is moving beyond prescriptions to preventative testing. Hims & Hers (HIMS 3.72%) announced today the launch of an early detection cancer test, bringing more value to its lab business. This is another product launch that isn't about pushing pills or slotting into the existing insurance ecosystem; it's fundamentally disruptive to the medical industry. In this video, I explain why this is the kind of product launch investors should want to see and why it will make the business much more valuable over the next decade. *Stock prices used were end-of-day prices of Feb. 4, 2026. The video was published on Feb. 4, 2026.
Key Points Johnson & Johnson's growth rate improved this past year, and that trend is likely to continue. The company sees a lot of growth ahead, particularly in its oncology business. 10 stocks we like better than Johnson & Johnson › Johnson & Johnson (NYSE: JNJ) is one of the largest healthcare companies in the world. But it hasn't always been a terribly exciting business to invest in. While it ...
Key Points Johnson & Johnson's growth rate improved this past year, and that trend is likely to continue. The company sees a lot of growth ahead, particularly in its oncology business. 10 stocks we like better than Johnson & Johnson › Johnson & Johnson (NYSE: JNJ) is one of the largest healthcare companies in the world. But it hasn't always been a terribly exciting business to invest in. While it has been growing, it's typically been at a modest pace. The main reason for investing in the stock has been its dividend. The company, however, has been investing in its pipeline in the hopes of achieving better growth in the future. And that looks to be paying off, as the company recently unveiled promising guidance for the year ahead. Could Johnson & Johnson stock be a potential bargain buy in 2026? Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue » Johnson & Johnson expects much more growth ahead Last month, Johnson & Johnson reported its full-year results for 2025. It was another solid year for the business, with revenue climbing by 6% to $94.2 billion. That's in line with what investors have come to expect from the business in recent years. In 2024, its top line rose by a more modest rate of 4%, but for the large part, single-digit growth has been the norm for Johnson & Johnson. Business, however, is trending higher. The company's CEO, Joaquin Duato, believes that more growth is on the horizon, saying, "We have line of sight to double-digit growth by the end of the decade." A big part of the reason for this growth is oncology, as Johnson & Johnson wants to be the leading cancer drugmaker in the world. It's hoping to bring in $50 billion from its oncology business, which is roughly double what it generated this past year. Is the stock a steal of a deal? For 2026, Johnson & Johnson management projects revenue of $100.5 billion, implying a growth rate of around 6.7%. Its top line is showin...
(RTTNews) - Powell Industries, Inc. (POWL) shares surged 21.11 percent, or $95.66, to $548.90 after reporting higher first-quarter earnings compared with last year. The company posted net income of $41.39 million, or $3.40 per share, up from $34.76 million, or $2.86 per share, a year earlier. Revenue increased 4.0 percent to $251.18 million from $241.43 million. The stock opened at $465.83 after a...
(RTTNews) - Powell Industries, Inc. (POWL) shares surged 21.11 percent, or $95.66, to $548.90 after reporting higher first-quarter earnings compared with last year. The company posted net income of $41.39 million, or $3.40 per share, up from $34.76 million, or $2.86 per share, a year earlier. Revenue increased 4.0 percent to $251.18 million from $241.43 million. The stock opened at $465.83 after a previous close of $453.24 and traded between $457.99 and $569.80 during the session on the Nasdaq. Volume totaled about 0.31 million shares, above the average of 0.24 million. Powell Industries' 52-week range stands at $146.02 to $569.80. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
aluxum/E+ via Getty Images Information Services Group, Inc. ( III ) is a small-cap software platform company that, surprisingly, seems fairly valued and unlikely to grow much. The problem here isn't a bad product, but it may be that it's just not that necessary. Business Model ISG bills itself as a "global AI-centered technology research and advisory firm." In general, they assist clients, typical...
aluxum/E+ via Getty Images Information Services Group, Inc. ( III ) is a small-cap software platform company that, surprisingly, seems fairly valued and unlikely to grow much. The problem here isn't a bad product, but it may be that it's just not that necessary. Business Model ISG bills itself as a "global AI-centered technology research and advisory firm." In general, they assist clients, typically large businesses, integrate technology into their business operations, something like guidance for their IT operations. Sept. 2025 Investor Presentation This platform-based model necessarily entails a wide variety of services. For the most part, the value they provide is cost-reduction and optimization, as modest improvement with large clients adds up to big savings. The emergence of generative AI has created more opportunities here. Sept. 2025 Investor Presentation Handy examples of the services they provide include: Vendor Sourcing Advisory and Strategy IT Service Benchmarking and Performance Analysis Network and Telecom Optimization Change Management (large-scale transitions) Proprietary Research and Trend Reports It's a business of helping other businesses improve their bottom lines through technology, from the purchase of a software product to its implementation. Revenue is primarily an advisory fee for providing these services. Financial History This sounds like it should be a fairly capital-light business with plenty of operating leverage as it scales out. Nevertheless, I think the financial history shows us something different. Author's display of 10K data For one, revenue generally did not grow for the period of 2015 to 2024, almost looking like a cyclical of a platform-based model. Author's display of 10K data The history of free cash flow shows a similarly stunted trend, with 2020 and 2021 mainly showing large figures amid favorable fluctuations in working capital for those years. TTM FCF has been about $27M. Income Statement (Q3 2025 Form 10Q) The first nine ...
NongAsimo/iStock via Getty Images By Wenli Bill Hao Beyond being a familiar adage, “quality over quantity” lies at the heart of quality-based investing. Rather than concentrating on the largest stocks, quality indices systematically tilt toward companies with strong profitability, high earnings quality and robust balance sheets. Over the long term, the S&P 500 ® Quality Index has delivered impress...
NongAsimo/iStock via Getty Images By Wenli Bill Hao Beyond being a familiar adage, “quality over quantity” lies at the heart of quality-based investing. Rather than concentrating on the largest stocks, quality indices systematically tilt toward companies with strong profitability, high earnings quality and robust balance sheets. Over the long term, the S&P 500 ® Quality Index has delivered impressive absolute and risk-adjusted returns as a result of tracking fundamentally sound businesses. In 2026, the index is off to a good start, outperforming the S&P 500 by 1.68% as of Jan. 30, 2026. In this blog, we’ll explore the key selection metrics behind the S&P 500 Quality Index, review its long-term and YTD performance, and analyze its current constituent makeup. Methodology Overview The S&P 500 Quality Index uses three key metrics: return on equity (ROE), balance sheet accruals ratio (BSA) and financial leverage ratio (FLR). These metrics are combined into an overall quality score, which is used to select the top 100 stocks within the S&P 500. Selected constituents are then weighted based on the product of their market capitalization and quality scores. 1 Long-Term Outperformance Over the long term, including back-tested results, the S&P 500 Quality Index has delivered robust performance, outperforming the 500 ® by an annualized 256 bps (13.71% vs. 11.15% annualized return) since Dec. 16, 1994, while also exhibiting 87 bps lower risk (17.97% vs. 18.84% annualized volatility). In contrast, the S&P 500 Quality – Lowest Quintile Index - representing the lowest quality quintile - has underperformed the S&P 500 by an annualized 180 bps over the same period (9.35% vs. 11.15% annualized return), while exhibiting a materially higher risk of 320 bps (22.04% vs. 18.84% annualized volatility). Together, these results highlight the pronounced performance divergence between high- and low-quality stocks (see Exhibit 2). Outperformance YTD in 2026 Resilient U.S. economic growth and low...
Public Service Enterprise Group (PEG) has quietly undergone a regime change, and the market is only beginning to price it in. After spending much of 2025 locked in a grinding consolidation, PEG has now broken above its bearish trendline, signaling a transition from defense to accumulation. What was once viewed as a slow-growth regulated utility is increasingly being reclassified as a strategic pro...
Public Service Enterprise Group (PEG) has quietly undergone a regime change, and the market is only beginning to price it in. After spending much of 2025 locked in a grinding consolidation, PEG has now broken above its bearish trendline, signaling a transition from defense to accumulation. What was once viewed as a slow-growth regulated utility is increasingly being reclassified as a strategic provider of infrastructure for the AI era. As nuclear power regains its premium status for data-center demand, PEG's asset base is emerging as far more valuable than its valuation suggests. Trade timing & outlook PEG recently broke above its descending trendline that had capped rallies since mid-2025, confirming a shift in short-term momentum. Trendline breakout: The stock has cleared a multi-month downtrend and is now holding above former resistance near $80, which should act as first support. Measured move target: The height of the base projects upside toward the $90 zone if the breakout continues. Fundamentals PEG's valuation remains reasonable relative to both its peers and its improving growth profile: Forward P/E: ~18x vs. Industry Average ~18x Expected EPS Growth: ~8.6% vs. Industry ~7.7% Expected Revenue Growth: ~7.1% vs. Industry ~5.9% Net Margins: ~17.8% vs. Industry ~14.5% Unlike many utilities that are rate-base driven, PEG combines the stability of regulated cash flows with unregulated nuclear optionality — a strategically valuable combination. Bullish thesis The nuclear premium: PEG controls critical nuclear assets in the Northeast (PJM) where hyperscalers are aggressively seeking 24/7 carbon-free baseload power. Government protection: The nuclear production tax credit effectively places a floor under nuclear economics, de-risking cash flows. Capital discipline: Management avoided offshore wind exposure and allocated capital toward transmission, uprates and preserving balance-sheet strength. Options trade To express a bullish view with defined risk and asymmetric...